Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amol Mujoomdar

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Cancer Research and Clinical Oncology|June 10, 2021
Survival predictors of <sup>177</sup>Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)Mina M Swiha, Duncan E K Sutherland, Golmehr Sistani, et al.
Canadian Liver Journal|July 18, 2025
Effectiveness of Retrograde Transvenous Obliteration for Primary Prophylaxis of Gastric Variceal BleedingNisha Howarth, Yashasavi Sachar, Derek Hw Little, et al.
Cancer Treatment Reviews|March 16, 2023
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in CanadaJason K Wong, Howard J Lim, Vincent C Tam, et al.
Journal of Clinical Epidemiology|April 5, 2023
Development of an international glossary for clinical guidelines collaborationRachel E Christensen, Michael D Yi, Bianca Y Kang, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Cancer Research and Clinical Oncology|June 10, 2021
Survival predictors of <sup>177</sup>Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)Mina M Swiha, Duncan E K Sutherland, Golmehr Sistani, et al.
Canadian Liver Journal|July 18, 2025
Effectiveness of Retrograde Transvenous Obliteration for Primary Prophylaxis of Gastric Variceal BleedingNisha Howarth, Yashasavi Sachar, Derek Hw Little, et al.
Cancer Treatment Reviews|March 16, 2023
Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in CanadaJason K Wong, Howard J Lim, Vincent C Tam, et al.
Journal of Clinical Epidemiology|April 5, 2023
Development of an international glossary for clinical guidelines collaborationRachel E Christensen, Michael D Yi, Bianca Y Kang, et al.
Pageof 3